Publizoom

Call for tenders Supplies

Farmaceutische preparaten op basis van infliximab IV

Notice published in Dutch. The AI analysis summarises it for you in your language.

Tenders due closed — 19 October 2026 at 11:00

Public buyer
Healthcare Public Procurement (HeCaPP)
Saint-Gilles\Sint-Gillis
Place of performance
1020 Bruxelles\Brussel, Brussels-Capital
Procedure
Open procedure
Any company may submit a bid.
Publication
16 September 2026
Notice language
Dutch

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Spécialités pharmaceutiques à base d'infliximab IV

2 lots

  • Spécialités pharmaceutiques à base d'infliximab (poudre pour solution à diluer pour solution pour perfusion)
  • Spécialités pharmaceutiques à base d'infliximab (solution "liquide" à diluer pour solution pour perfusion)

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Winning prices for comparable contracts

A quarter below
€269,390
Median
€449,863
A quarter above
€962,736

Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Likely competitors: who wins with this buyer in this field

Partners and subcontractors

Contract too big or too broad for you alone? Bid as a temporary consortium, or offer your services as a subcontractor.

Create your free account to see who is looking for a partner on this contract, and to register.

Companies winning this type of contract in the region

Possible partners for a temporary consortium or subcontracting… and competitors worth knowing.

Similar contracts already awarded

ContractWinnerAmount
Farmaceutische specialiteiten op basis van piperacilline/tazobactam, flucloxacilline, linezolid, benzylpenicilline (natrium), vancomycine (hydrochloride), ceftazidime, meropenem (trihydraat), ciprofloxacine en ceftriaxon
Healthcare Public Procurement (HeCaPP) · 31 August 2026
Viatris
Fresenius Kabi
sandoz
€1,646,683
Spécialité pharmaceutique à base de (li)pegfilgrastim
Healthcare Public Procurement (HeCaPP) · 18 August 2026
ACCORD HEALTHCARE €656,000
Spécialités pharmaceutiques à base de glecaprévir/pibrentasvir
Healthcare Public Procurement (HeCaPP) · 18 August 2026
Abbvie SA €2,856,000
spécialités pharmaceutiques à base de solutions de perfusion standard de NaCl 0,9%, de Glucose 5%, de Ringer lactate, de Glucose 10%, de Glucose 5% + NaCl 0,9%, d'eau stérile et de solution d'électrolytes isotonique (sans tampon lactate) et spécialités pharmaceutiques à base de solutions d'irrigation de NaCl 0,9%, de Glycine 1,5% et d'Eau stérile
Healthcare Public Procurement (HeCaPP) · 1 July 2026
B. BRAUN MEDICAL
BAXTER BELGIUM
€5,294,599
Farmaceutische specialiteiten op basis van fluconazol, voriconazol, anidulafungine, posaconazol en caspofungine
Healthcare Public Procurement (HeCaPP) · 29 June 2026
SANDOZ SA
Pfizer
Fresenius Kabi NV/SA
€186,652

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 637432-2026.